Does Harvard Pilgrim Health Care Cover Mounjaro?
The verdict
Conditional on most plans
Harvard Pilgrim Health Care (part of Point32Health, which also owns Tufts Health Plan) covers Mounjaro for type 2 diabetes with prior authorization across commercial, ACA, and Medicare lines. Harvard Pilgrim does not cover Mounjaro for weight loss. Massachusetts Medicaid covers Mounjaro for diabetes; the weight-loss products (Wegovy, Zepbound) are restricted under MA Medicaid. The weight-loss tirzepatide is Zepbound, with separate coverage.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Harvard Pilgrim Health Care using your member ID.
Key facts
Harvard Pilgrim Health Care is part of Point32Health alongside Tufts Health Plan — both New England plans share formulary architecture for Mounjaro T2D coverage with prior authorization.
Point32Health / Harvard Pilgrim Health Care Plan Information
Massachusetts Medicaid (MassHealth) covers Mounjaro for type 2 diabetes with PA; the weight-loss products Wegovy and Zepbound are restricted under MA Medicaid.
MassHealth (Massachusetts Medicaid) Preferred Drug List
The 2026 Medicare Part D out-of-pocket cap is $2,100. Most Mounjaro users for diabetes who stay on therapy continuously reach this cap within 2–3 months and pay $0 for the rest of the year.
CMS Medicare Part D Redesign, 2026
Medicare vs. commercial coverage
Whether Harvard Pilgrim Health Care covers Mounjaro depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Harvard Pilgrim Medicare Advantage and Part D plans cover Mounjaro for type 2 diabetes only — not weight loss — with prior authorization. The 2026 Part D out-of-pocket cap is $2,100; most continuous Mounjaro users for diabetes reach it within 2–3 months and pay $0 for the remainder of the year. The IRA-negotiated Medicare MFN price of $245/month begins mid-2026. Mounjaro is NOT included in the 2026 Medicare GLP-1 Bridge ($50/month), which covers weight-loss-approved products only. The Lilly savings card is not usable by Medicare or Medicaid beneficiaries.
Commercial / Employer
Group & marketplace plans
Harvard Pilgrim commercial and employer-sponsored plans: Mounjaro is covered for type 2 diabetes with prior authorization (A1c 6.5% or higher, metformin trial). Specific tier placement is not publicly confirmed at the drug level — verify on the Harvard Pilgrim formulary. Harvard Pilgrim is part of Point32Health alongside Tufts Health Plan — both plans share formulary architecture. Not covered for off-label weight loss. ACA/Individual: diabetes only, PA; weight-loss GLP-1s commonly excluded. Massachusetts Medicaid: covers Mounjaro for diabetes; Wegovy and Zepbound are restricted. Lilly savings card: $25/month with commercial coverage; $499/month without (max $647/month, up to 13 fills, expires 12/31/2026). Not available to Medicare or Medicaid beneficiaries.
The 5 boxes you must tick to get approved
Commercial plans that will consider Mounjaro require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Mounjaro actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $1,300–$1,560/month retail (WAC ~$1,080). Lilly savings card: $499/month for commercially insured without coverage (max $647/month, up to 13 fills, expires 12/31/2026). Not available to Medicare or Medicaid beneficiaries.
List price with no coverage — before any manufacturer savings card.
With coverage
Harvard Pilgrim plan-specific brand cost-share; tier not publicly confirmed at the drug level — verify on the Harvard Pilgrim drug lookup. Commercially insured with Mounjaro coverage may pay as little as $25/month via the Lilly savings card. Massachusetts Medicaid: nominal copay for covered T2D use. Medicare Part D: 25% coinsurance to the $2,100 OOP cap 2026; MFN $245/month mid-2026.
Typical monthly copay once prior authorization is approved.
Bridge program
The 2026 Medicare GLP-1 Bridge ($50/month) covers weight-loss-approved products only; Mounjaro is not included.
Reduced copay through the assistance program, where eligible.
All figures are estimates; confirm cost-share on the Harvard Pilgrim drug lookup tool. The Lilly savings card expires 12/31/2026 and is not available to Medicare, Medicaid, or government-program beneficiaries.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Verify Mounjaro coverage on the Harvard Pilgrim drug formulary
Visit harvardpilgrim.org and use the drug lookup for your specific plan. Confirm that PA is required, look up the current tier and cost-share, and verify the PA criteria. Harvard Pilgrim is part of Point32Health — if you are also considering Tufts Health Plan (the sister plan), coverage terms are similar but verify separately.
- 2
Have your prescriber submit a complete prior authorization
Your prescriber must document your T2D diagnosis (ICD-10 E11.x), A1c of 6.5% or greater within ~90 days, and prior metformin trial (plus one additional agent where required). Submit through the Harvard Pilgrim PA portal; allow up to 72 hours for a decision.
- 3
If you want tirzepatide for weight loss, ask about Zepbound — not Mounjaro
If your goal is weight loss rather than diabetes management, Mounjaro will be denied. The weight-loss tirzepatide is Zepbound, FDA-approved for chronic weight management and OSA. Massachusetts restricts weight-loss GLP-1s under Medicaid — ask your prescriber and Harvard Pilgrim about Zepbound coverage on your specific commercial or Medicare plan.
Options if Harvard Pilgrim Health Care won't cover Mounjaro
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Ozempic (semaglutide)
FDA-approved for type 2 diabetes. May be on a preferred tier ahead of Mounjaro as step therapy on Harvard Pilgrim formularies.
Trulicity (dulaglutide)
FDA-approved for T2D. GLP-1 alternative; often used as a step-therapy agent before Mounjaro approval.
Jardiance (empagliflozin)
SGLT2 inhibitor for T2D with cardiovascular benefits. May be required step therapy before GLP-1 approval on Harvard Pilgrim plans.
Tufts Health Plan (Point32Health sister)
Tufts Health Plan is the sister plan under Point32Health. Both share formulary architecture for Mounjaro T2D coverage; verify separately if you are considering Tufts.
Zepbound (tirzepatide) — weight loss only
Same molecule as Mounjaro (tirzepatide) but FDA-approved for chronic weight management and OSA. MA Medicaid restricts weight-loss GLP-1s — ask specifically about Zepbound commercial coverage. Separate track from Mounjaro.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. Harvard Pilgrim does not cover Mounjaro for weight loss. Mounjaro is FDA-approved for type 2 diabetes only; the PA is gated on a T2D diagnosis — off-label weight-loss requests are denied. For weight loss, the same active ingredient (tirzepatide) is Zepbound — a separate FDA approval for chronic weight management and OSA. Massachusetts Medicaid restricts weight-loss GLP-1s, so Zepbound coverage is also limited in that line of business.
Point32Health is the New England insurance holding company formed by the merger of Harvard Pilgrim Health Care and Tufts Health Plan. Both brands continue to operate; they share formulary architecture for Mounjaro and other specialty drugs. If you are considering both plans, verify Mounjaro tier and PA requirements separately on the Harvard Pilgrim and Tufts drug lookup tools, as plan-specific cost-share may differ.
Massachusetts Medicaid (MassHealth) covers Mounjaro for type 2 diabetes with prior authorization. The weight-loss products — Wegovy and Zepbound — are restricted under MA Medicaid. If you are on MassHealth, the Lilly savings card is not available; verify cost-share on your specific plan. Mounjaro for weight loss is not covered under MassHealth.
No. The 2026 Medicare GLP-1 Bridge ($50/month, July 1 – December 31, 2027) covers weight-loss-approved products only — Wegovy, Foundayo, and the Zepbound KwikPen. Mounjaro is excluded because it is FDA-approved for type 2 diabetes, not weight loss. Harvard Pilgrim Medicare Advantage and Part D plans cover Mounjaro under standard Part D rules for T2D, with PA and the $2,100 annual OOP cap in 2026.
Related Articles
Does Quartz Health Solutions Cover Mounjaro? 2026 | Curex
Quartz Health Solutions (WI) covers Mounjaro for type 2 diabetes with prior auth — not weight loss. Composite plan; verify on Quartz formulary.
Read moreDoes Geisinger Health Plan Cover Mounjaro? 2026 Guide | Curex
Geisinger covers Mounjaro for type 2 diabetes with prior auth — not weight loss. PA Medicaid is diabetes-only after the 2025 weight-loss GLP-1 cut.
Read moreDoes Health Net Cover Ozempic? 2026 Coverage Guide | Curex
Health Net covers Ozempic for type 2 diabetes with prior auth — not weight loss. Medi-Cal T2D covered. Verify tier on Health Net drug lookup tool.
Read moreDoes Harvard Pilgrim Health Care Cover Ozempic? 2026 | Curex
Harvard Pilgrim covers Ozempic for type 2 diabetes with prior auth, not weight loss. NE Point32Health plan; T2D unaffected by GLP-1 weight-loss cuts.
Read moreDoes Health Net Cover Mounjaro? California 2026 | Curex
Health Net (Centene, CA) covers Mounjaro for type 2 diabetes with prior auth — not weight loss. Medi-Cal excludes weight-loss GLP-1s from 1/1/2026.
Read moreDoes Harvard Pilgrim Health Care Cover Wegovy? 2026 | Curex
Harvard Pilgrim covers Wegovy only where your employer opted in. New England GLP-1 market tightening — BCBS-MA exited 2026. Verify on the drug-lookup tool.
Read moreInsurance covers Mounjaro only for diabetes — for weight loss, here's a path that skips insurance
Harvard Pilgrim covers Mounjaro for diabetes only, not weight loss — and Massachusetts restricts the weight-loss GLP-1s. For patients who want tirzepatide access without insurance, compounded tirzepatide from $149/mo (and compounded semaglutide from $49/mo) is available at getcurex.com/cl/glp — no insurance required, no prior authorization. This is compounded tirzepatide and is not the same medication as Mounjaro or Zepbound. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Mounjaro and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Harvard Pilgrim Health Care before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Mounjaro and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.